Search

Your search keyword '"Perdona, Sisto"' showing total 16 results
Start Over Author "Perdona, Sisto" Publisher elsevier b.v.
16 results on '"Perdona, Sisto"'

1. Single bladder instillation of gemcitabine versus mitomycin C after minimally invasive radical nephroureterectomy: A propensity-score match analysis from the ROBUUST 2.0 collaborative group

Author

Bologna, Eugenio, Wu, Zhenjie, Franco, Antonio, Abdollah, Firas, Finati, Marco, Simone, Giuseppe, Tuderti, Gabriele, Licari, Leslie Claire, Correa, Andres F., Lee, Randall, De Cobelli, Ottavio, Ferro, Matteo, Porpiglia, Francesco, Amparore, Daniele, Checcucci, Enrico, Tufano, Antonio, Perdonà, Sisto, Bhanvadia, Raj, Margulis, Vitaly, Brönimann, Stephan, Singla, Nirmish, Puri, Dhruv, Derweesh, Ithaar H., Mendiola, Dinno F., Gonzalgo, Mark L., Ben-David, Reuben, Mehrazin, Reza, Moon, Sol C., Rais-Bahrami, Soroush, Yong, Courtney, Sundaram, Chandru P., Ghoreifi, Alireza, Moghaddam, Farshad S., Djaladat, Hooman, Ditonno, Francesco, Antonelli, Alessandro, and Autorino, Riccardo

Published
2025
Full Text
View/download PDF

2. A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors

Author

Pandolfo, Savio Domenico, Cerrato, Clara, Wu, Zhenjie, Franco, Antonio, Del Giudice, Francesco, Sciarra, Alessandro, Verze, Paolo, Lucarelli, Giuseppe, Imbimbo, Ciro, Perdonà, Sisto, Cherullo, Edward E., Porpiglia, Francesco, Derweesh, Ithaar H., and Autorino, Riccardo

Published
2023
Full Text
View/download PDF

4. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis

Author

Yim, Kendrick, Aron, Monish, Rha, Koon H., Simone, Giuseppe, Minervini, Andrea, Challacombe, Ben, Schips, Luigi, Berardinelli, Francesco, Quarto, Giuseppe, Mehrazin, Reza, Patel, Devin, Patel, Sunil, Bindayi, Ahmet, Ashrafi, Akbar N., Desai, Mihir, Alqahtani, Ali, Gallucci, Michele, Sulek, Jay, Mari, Andrea, De Luyk, Nicolo, Anele, Uzoma, Autorino, Riccardo, Porpiglia, Francesco, Sundaram, Chandru P., Gill, Inderbir S., Perdona, Sisto, and Derweesh, Ithaar H.

Published
2021
Full Text
View/download PDF

5. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer

Author

Cantiello, Francesco, Russo, Giorgio I., Vartolomei, Mihai Dorin, Farhan, Abdal Rahman Abu, Terracciano, Daniela, Musi, Gennaro, Lucarelli, Giuseppe, Di Stasi, Savino M., Hurle, Rodolfo, Serretta, Vincenzo, Busetto, Gian Maria, Scafuro, Chiara, Perdonà, Sisto, Borghesi, Marco, Schiavina, Riccardo, Cioffi, Antonio, De Berardinis, Ettore, Almeida, Gilberto L., Bove, Pierluigi, Lima, Estevao, Ucciero, Giuseppe, Matei, Deliu Victor, Crisan, Nicolae, Verze, Paolo, Battaglia, Michele, Guazzoni, Giorgio, Autorino, Riccardo, Morgia, Giuseppe, Damiano, Rocco, de Cobelli, Ottavio, Mirone, Vincenzo, Shariat, Shahrokh F., and Ferro, Matteo

Published
2018
Full Text
View/download PDF

6. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group)

Author

Bertolo, Riccardo, Autorino, Riccardo, Simone, Giuseppe, Derweesh, Ithaar, Garisto, Juan D., Minervini, Andrea, Eun, Daniel, Perdona, Sisto, Porter, James, Rha, Koon Ho, Mottrie, Alexander, White, Wesley M., Schips, Luigi, Yang, Bo, Jacobsohn, Kenneth, Uzzo, Robert G., Challacombe, Ben, Ferro, Matteo, Sulek, Jay, Capitanio, Umberto, Anele, Uzoma A., Tuderti, Gabriele, Costantini, Manuela, Ryan, Stephen, Bindayi, Ahmet, Mari, Andrea, Carini, Marco, Keehn, Aryeh, Quarto, Giuseppe, Liao, Michael, Chang, Kidon, Larcher, Alessandro, De Naeyer, Geert, De Cobelli, Ottavio, Berardinelli, Francesco, Zhang, Chao, Langenstroer, Peter, Kutikov, Alexander, Chen, David, De Luyk, Nicolo, Sundaram, Chandru P., Montorsi, Francesco, Stein, Robert J., Haber, Georges Pascal, Hampton, Lance J., Dasgupta, Prokar, Gallucci, Michele, Kaouk, Jihad, and Porpiglia, Francesco

Published
2018
Full Text
View/download PDF

8. Prostate Cancer Detection in the “Grey Area” of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun’s Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3

Author

Perdonà, Sisto, Cavadas, Vitor, Di Lorenzo, Giuseppe, Damiano, Rocco, Chiappetta, Gennaro, Del Prete, Paola, Franco, Renato, Azzarito, Giuseppina, Scala, Stefania, Arra, Claudio, De Sio, Marco, and Autorino, Riccardo

Published
2011
Full Text
View/download PDF

16. Characteristics, trends, and management of Penile cancer in the United States: A population-based study.

Author

Bologna, Eugenio, Licari, Leslie Claire, Franco, Antonio, Ditonno, Francesco, Manfredi, Celeste, De Nunzio, Cosimo, Perdona, Sisto, Brassetti, Aldo, Leonardo, Costantino, Coogan, Christopher L., Cherullo, Edward E., and Autorino, Riccardo

Subjects
*PENILE cancer, *THERAPEUTICS, *LICHEN sclerosus et atrophicus, *SYMPTOMS, *SURGICAL excision, *CONSERVATIVE treatment
Abstract

• Despite major efforts in the management of PeCa aimed at improving staging and consequently providing more solid indications for OSS, there hasn't been a notable shift towards more conservative treatments. • Surgeries for advanced-stage tumors are still marked by high rates of complications potentially affect the sexual and psychosocial health of patients. • Mutations in SWI-SNF complex and inactivated JAK-STAT signaling enriched at relapse. • These issues may foster a tendency toward avoidance behaviors, contributing to a delayed clinical presentation of the disease as well as its treatment. Penile cancer (PeCa) is a rare disease. HPV infection, smoking, phimosis, and lichen sclerosus represent well-known associated risk factors. Primary aim of our study is to evaluate the incidence and risk factors of PeCa and to outline the adopted diagnostic and therapeutic approaches. Secondary aim is to investigate risk factors associated with aggressive disease and to identify the complications arising from its surgical treatment. We conducted a retrospective analysis using the PearlDiver™ Mariner database, from January 1, 2011, to December 31, 2021, identifying all patients diagnosed with PeCa and PeIN, evaluating comorbidities, risk factors, and social and economic conditions. We evaluated the imaging modalities employed for staging as well as the treatment strategies. Finally, we evaluated the most frequent complications associated with inguinal lymphadenectomy (ILND). During the study period, 17,494 patients were diagnosed with PeCa and 5,965 with penile intraepithelial neoplasia (PeIN). US was the most frequently utilized imaging modality, followed by PET and PET/CT. Use of CT and MRI was around 5%. Surgical treatment was the predominant strategy, utilized in 31.3% of PeCa and 22.9% of PeIN. Wide Local Excision/Glansectomy emerged as the most common surgical procedures. MLR analysis identified smoking as a risk factor for metastatic PeCa (OR; 95% CI = 1.49; 1.379–1.609), HPV infections were associated with a 35% decrease in risk (OR; 95% CI = 0.65; 0.562–0.744) (all P < 0.001). Lichen sclerosus and phimosis were associated with a doubled risk of demolitive surgery. Approximately 40% of patients experienced complications associated with ILND. Despite advances in PeCa management, there's no significant move toward more conservative treatments. Surgical treatments are still marked by high rates of complications, potentially affect the sexual and psychosocial health of patients. These issues may foster a tendency toward avoidance behaviors, contributing to a delayed clinical presentation and treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results